[Chemotherapy for bladder cancer: 2012 Update. From AUO ("Arbeitsgemeinschaft Urologische Onkologie") and IABC ("Interdisziplinäre Arbeitsgruppe BlasenCarcinom")]

M M Heck; J E Gschwend; M Retz; Arbeitsgemeinschaft Urologische Onkologie; Interdisziplinäre Arbeitsgruppe BlasenCarcinom

doi:10.1007/s00120-012-2822-9

[Chemotherapy for bladder cancer: 2012 Update. From AUO ("Arbeitsgemeinschaft Urologische Onkologie") and IABC ("Interdisziplinäre Arbeitsgruppe BlasenCarcinom")]

Urologe A. 2012 Jun;51(6):829-36. doi: 10.1007/s00120-012-2822-9.

[Article in German]

Authors

M M Heck¹, J E Gschwend, M Retz; Arbeitsgemeinschaft Urologische Onkologie; Interdisziplinäre Arbeitsgruppe BlasenCarcinom

Affiliation

¹ Klinikum rechts der Isar, Urologische Klinik und Poliklinik der Technischen Universität München, Ismaninger Straße 22, 81675 München. [email protected]

PMID: 22526172
DOI: 10.1007/s00120-012-2822-9

Abstract

This article summarizes contemporary standards in systemic therapy for urothelial carcinoma as well as updated results of peer-reviewed publications and international bladder cancer meetings in 2011. Both neoadjuvant and adjuvant trials for locally advanced carcinoma and data on systemic chemotherapy for metastatic bladder cancer are discussed.

Publication types

English Abstract
Practice Guideline

MeSH terms

Antineoplastic Agents / therapeutic use*
Drug Therapy / standards*
Germany
Humans
Medical Oncology / standards*
Urinary Bladder Neoplasms / drug therapy*
Urology / standards*

Substances

Antineoplastic Agents